You just read:

Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO™ Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma

News provided by

Halozyme Therapeutics, Inc.

May 01, 2020, 15:16 ET